I

n a victory for the pharmaceutical industry, the U.S. Supreme Court limited the right for people from anywhere in the country to file product-liability lawsuits against drug makers in California and several other states where courts are seen as more hospitable to consumers.

The ruling came in response to a debate over jurisdiction, which can be used to determine where a lawsuit may be filed. Last year, the California Supreme Court clarified the extent to which Bristol-Myers Squibb needed to have a presence in California in order to be sued by hundreds of people from Texas, Ohio, and 33 other states, who claim they were harmed by its Plavix blood thinner.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.